NPI: 1205104841 · WAYNE, NJ 07470 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 12/11/2011
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 12/11/2011 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 8,999 | $585K |
| 2019 | 5,102 | $240K |
| 2020 | 2,547 | $188K |
| 2021 | 2,391 | $199K |
| 2022 | 6,604 | $230K |
| 2023 | 3,723 | $103K |
| 2024 | 2,743 | $72K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 19,312 | 1,489 | $1.33M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 6,041 | 380 | $115K |
| J1270 | Injection, doxercalciferol, 1 mcg | 1,399 | 121 | $68K |
| A4657 | Syringe, with or without needle, each | 2,291 | 810 | $30K |
| J1756 | Injection, iron sucrose, 1 mg | 1,169 | 308 | $27K |
| 82728 | 306 | 281 | $8K | |
| 83970 | 283 | 282 | $8K | |
| 83550 | 293 | 268 | $8K | |
| 83540 | 293 | 268 | $8K | |
| 85048 | 223 | 219 | $4K | |
| 85041 | 250 | 231 | $4K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 66 | 64 | $2K |
| 82108 | 34 | 33 | $2K | |
| 82607 | 32 | 31 | $2K | |
| 82746 | 33 | 32 | $2K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 25 | 13 | $0.00 |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 59 | 25 | $0.00 |